Fed. Circ. Rules Myriad Can Patent Breast Cancer Genes
The Federal Circuit on Friday ruled that two breast cancer genes isolated by Myriad Genetics Inc. are patentable inventions in a precedential victory for the biotechnology industry, though the court also...To view the full article, register now.
Already a subscriber? Click here to view full article